🇺🇸 FDA
Patent

US 6780406

Inhibition of vascular smooth muscle cell proliferation administering a thymidine kinase gene

expired A61KA61K38/45A61K48/00

Quick answer

US patent 6780406 (Inhibition of vascular smooth muscle cell proliferation administering a thymidine kinase gene) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Aug 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Aug 24 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K38/45, A61K48/00, A61P, A61P9/08